Get started
Author

Suchitra Natarajan

ORCID: 0009-0004-8774-8763
Observed ORCID: 0009-0004-8774-8763
OpenAlex ID: A5009769002
Abdominal FLASH irradiation reduces radiation-induced gastrointestinal toxicity for the treatment of ovarian cancer in mice
2020 · Karen Levy, Suchitra Natarajan, et al. · Scientific Reports · 278
PDF
Cancer-associated mesothelial cells promote ovarian cancer chemoresistance through paracrine osteopontin signaling
2021 · Jin Qian, Bauer L. LeSavage, et al. · Journal of Clinical Investigation · 130
PDF
Collagen Remodeling in the Hypoxic Tumor-Mesothelial Niche Promotes Ovarian Cancer Metastasis
2019 · Suchitra Natarajan, Kaitlyn M. Foreman, et al. · Cancer Research · 128
Abdominopelvic FLASH Irradiation Improves PD-1 Immune Checkpoint Inhibition in Preclinical Models of Ovarian Cancer
2021 · Joshua T. Eggold, Stephanie Chow, et al. · Molecular Cancer Therapeutics · 99
HMGA2 Inhibits Apoptosis through Interaction with ATR-CHK1 Signaling Complex in Human Cancer Cells
2013 · Suchitra Natarajan, Sabine Hombach-Klonisch, et al. · Neoplasia · 59
PDF
Chaperoning HMGA2 Protein Protects Stalled Replication Forks in Stem and Cancer Cells
2014 · Haojie Yu, Hong Hwa Lim, et al. · Cell Reports · 56
PDF
Mechanisms of Therapeutic Resistance in Cancer (Stem) Cells with Emphasis on Thyroid Cancer Cells
2014 · Sabine Hombach-Klonisch, Suchitra Natarajan, et al. · Frontiers in Endocrinology · 36
PDF
Dovitinib enhances temozolomide efficacy in glioblastoma cells
2017 · Thatchawan Thanasupawat, Suchitra Natarajan, et al. · Molecular Oncology · 29
PDF
HMGA 2 as a functional antagonist of PARP 1 inhibitors in tumor cells
2018 · Sabine Hombach‐Klonisch, Forouh Kalantari, et al. · Molecular Oncology · 27
PDF
High Mobility Group A2 protects cancer cells against telomere dysfunction
2016 · Suchitra Natarajan, Farhana Begum, et al. · Oncotarget · 20
PDF
FLASH irradiation enhances the therapeutic index of abdominal radiotherapy for the treatment of ovarian cancer
2019 · Karen Levy, Suchitra Natarajan, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 18
PDF
Three-Dimensional Telomere Dynamics in Follicular Thyroid Cancer
2013 · Landon Wark, Adrian Danescu, et al. · Thyroid · 10
The RNA demethylase FTO promotes glutamine metabolism in clear cell renal cell carcinoma through the regulation of SLC1A5
2025 · Man Zhao, Dalin Zhang, et al. · Science Advances · 9
PDF
Abstract 5351: FLASH irradiation enhances the therapeutic index of abdominal radiotherapy in mice
2020 · Suchitra Natarajan, Karen Levy, et al. · Cancer Research · 8
Abstract TMIM-081: THE HYPOXIC TUMOR-MESOTHELIAL NICHE PROMOTES OVARIAN CANCER METASTASIS THROUGH COLLAGEN REMODELING
2019 · Suchitra Natarajan, Katie Foreman, et al. · Clinical Cancer Research · 3
Targeting AEBP1 to Mitigate Protumor Activity of Cancer-Associated Fibroblasts and Increase Therapeutic Efficacy of Anti–PD-1
2025 · Suchitra Natarajan, Khoa Nguyen, et al. · Molecular Cancer Therapeutics · 2
Targeting oncofetal high mobility group A2 (HMGA2) to increase sensitivity to temozolomide (TMZ) in glioblastoma (GB) cells
2014 · Suchitra Natarajan, Thatchawan Thanasupawat, et al. · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 2
PDF
In vitro models of cancer‐associated fibroblast heterogeneity uncover subtype‐specific effects of CRISPR perturbations
2025 · Elysia Saputra, Shamsudheen Karuthedath Vellarikkal, et al. · Molecular Oncology · 1
Supplementary Figure S5 from Targeting AEBP1 to Mitigate Protumor Activity of Cancer-Associated Fibroblasts and Increase Therapeutic Efficacy of Anti–PD-1
2026 · Suchitra Natarajan, Khoa Nguyen, et al.
Supplementary Figure S2 from Targeting AEBP1 to Mitigate Protumor Activity of Cancer-Associated Fibroblasts and Increase Therapeutic Efficacy of Anti–PD-1
2026 · Suchitra Natarajan, Khoa Nguyen, et al.
Figure S1 from Targeting AEBP1 to Mitigate Protumor Activity of Cancer-Associated Fibroblasts and Increase Therapeutic Efficacy of Anti–PD-1
2026 · Suchitra Natarajan, Khoa Nguyen, et al.
Supplementary Table S2 from Targeting AEBP1 to Mitigate Protumor Activity of Cancer-Associated Fibroblasts and Increase Therapeutic Efficacy of Anti–PD-1
2026 · Suchitra Natarajan, Khoa Nguyen, et al.
Supplementary Figure S3 from Targeting AEBP1 to Mitigate Protumor Activity of Cancer-Associated Fibroblasts and Increase Therapeutic Efficacy of Anti–PD-1
2026 · Suchitra Natarajan, Khoa Nguyen, et al.
Supplementary Figure S6 from Targeting AEBP1 to Mitigate Protumor Activity of Cancer-Associated Fibroblasts and Increase Therapeutic Efficacy of Anti–PD-1
2026 · Suchitra Natarajan, Khoa Nguyen, et al.
Supplementary Table S1 from Targeting AEBP1 to Mitigate Protumor Activity of Cancer-Associated Fibroblasts and Increase Therapeutic Efficacy of Anti–PD-1
2026 · Suchitra Natarajan, Khoa Nguyen, et al.
Works count: 45
Citation count: 805
H-index: 10
I10-index: 10
Year
Topic
Type